Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hiv infections
Phenotype C0041327|pulmonary tb
Sentences 5
PubMedID- 21834257 To highlight the burden of re-treatment smear positive pulmonary tb with and without hiv infection and determine how directly observed therapy (dot) using the retreatment regimen has affected the treatment outcome in the management of these patients.
PubMedID- 26064681 In hiv infected patients with pulmonary tb, 24–61% have acid-fast negative sputum smear [3].
PubMedID- 22096379 In several studies of hiv infected patients with pulmonary tb, the median cd4 t-cell count was <300 cells/μl.17 until 1993, two clinical presentations of tb/hiv co-infection were recognized; tb in the hiv-seropositive patients without aids and tb accompanied by aids.18 subsequently, the world health organization classified tb as an aids defining condition in hiv infected patients.19 the cd4 lymphocyte count, which defines the degree of immunosuppression, is used to compare the clinical radiological presentations.20 the cd4 lymphocyte count cut-off point has been defined as 200 cells/μl.
PubMedID- 23758662 Adult (≥18 years) pulmonary tb suspects with confirmed hiv infection and/or at high risk of mdr-tb are included after giving informed consent.
PubMedID- 21605474 Specifically, we aimed to investigate the burden of hiv infection among adults with smear-positive pulmonary tb, to examine changes over time, to describe current hiv management and compare with 2006 who guidelines [9], and investigate tb treatment outcomes among tb-hiv co-infected people.

Page: 1